FibroBiologics, Inc. Common Stock
$1.43
-$0.06 (-3.70%)
$1.40Day Range$1.54
Key Statistics
Market Cap
$9.95M
Shares Outstanding
7.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 31, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$1.54
Day High
$1.54
Day Low
$1.40
Volume
130.7K
VWAP
$1.45
Prev Close
$1.49
Transactions
--
Acc. Volume
--
About FibroBiologics, Inc. Common Stock
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
PHARMACEUTICAL PREPARATIONSSIC 283415 employees9350 KIRBY DRIVE, HOUSTON, TX, 77054281-671-5150IPO Jan 31, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001958777
- Composite FIGI
- BBG01K4MB400
- Share Class FIGI
- BBG01K4MB4V6
- Ticker Root
- FBLG
- SIC Code
- 2834
About FibroBiologics, Inc. Common Stock (FBLG) Stock
FibroBiologics, Inc. Common Stock (FBLG) closed the 2026-09-18 session at $1.43, down 3.70% versus the previous close (-0.06). The stock opened at $1.54 and traded between $1.40 and $1.54 during that session. Session trading volume was 131K shares. The volume-weighted average price (VWAP) is $1.45.
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
FibroBiologics, Inc. Common Stock has a market capitalization of $9.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. FBLG is listed on the XNAS exchange. The company employs approximately 15 people. FibroBiologics, Inc. Common Stock is headquartered in HOUSTON, TX. The recorded listing date is 2024-01-31.
On this page you can find market FBLG stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.